Loading publications…
The last 5 uploaded publications
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Gerrit Anne van Es, Eugène McFadden, Yoshinobu Onuma, Cokky van Meijeren, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Maurizio Ferrario, Aris Moschovitis, Aleksander Żurakowski, Marcello Dominici, Robert‐Jan van Geuns, Kurt Huber, Ton Slagboom, Patrick W. Serruys, Stephan Windecker, Mohamed Abdellaoui, David Adlam, İbrahim Akın, Agustín Albarrán González-Trevilla, Manuel Almeida, Pedro A. Lemos, Adel Aminian, Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber (2018). Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. The Lancet, 392(10151), pp. 940-949, DOI: 10.1016/s0140-6736(18)31858-0.
Article146 days agoComparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W. Serruys, Sigmund Silber, Scot Garg, Robert‐Jan van Geuns, Gert Richardt, Paweł Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauß, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Jacintha E. Ronden, Marco Bressers, Pierre Gobbens, Manuela Negoita, Frank N. van Leeuwen, Stephan Windecker (2010). Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents. New England Journal of Medicine, 363(2), pp. 136-146, DOI: 10.1056/nejmoa1004130.
Article146 days agoBiolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker, Patrick W. Serruys, Simon Wandel, Paweł Buszman, Stanisław Trznadel, Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Simon Davies, Robert‐Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni (2008). Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet, 372(9644), pp. 1163-1173, DOI: 10.1016/s0140-6736(08)61244-1.
Article146 days agoEffects of the Direct Lipoprotein-Associated Phospholipase A <sub>2</sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
Patrick W. Serruys, Héctor M. García‐García, Paweł Buszman, Paul Erné, Stefan Verheye, Michael Aschermann, Henrikus Duckers, Øyvind Bleie, Dariusz Dudek, Hans Erik Bøtker, Clemens von Birgelen, Don D'Amico, Tammy Hutchinson, Andrew Zambanini, Frits Mastik, Gerrit-Anne van Es, Antonius F.W. van der Steen, D. Geoffrey Vince, Peter Ganz, Christian W. Hamm, William Wijns, Andrew Zalewski (2008). Effects of the Direct Lipoprotein-Associated Phospholipase A <sub>2</sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque. Circulation, 118(11), pp. 1172-1182, DOI: 10.1161/circulationaha.108.771899.
Article146 days agoImproved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease
Patrick W. Serruys, Vasim Farooq, Bindu Kalesan, Ton de Vries, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Franz R. Eberli, William Wijns, Marie Claude Morice, Carlo Di Mario, Roberto Corti, Diethmar Antoni, Hae Young Sohn, Pedro Eerdmans, Tessa Rademaker‐Havinga, Gerrit‐Anne van Es, Bernhard Meier, Peter Jüni, Stephan Windecker (2013). Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 6(8), pp. 777-789, DOI: 10.1016/j.jcin.2013.04.011.
Article146 days ago